| Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis C Henchcliffe, MF Beal Nature clinical practice Neurology 4 (11), 600-609, 2008 | 972 | 2008 |
| Personalized iPSC-derived dopamine progenitor cells for Parkinson’s disease JS Schweitzer, B Song, TM Herrington, TY Park, N Lee, S Ko, J Jeon, ... New England Journal of Medicine 382 (20), 1926-1932, 2020 | 393 | 2020 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 300 | 2014 |
| The future of stem cell therapies for Parkinson disease M Parmar, S Grealish, C Henchcliffe Nature Reviews Neuroscience 21 (2), 103-115, 2020 | 274 | 2020 |
| Coenzyme Q10 effects in neurodegenerative disease M Spindler, MF Beal, C Henchcliffe Neuropsychiatric disease and treatment, 597-610, 2009 | 258 | 2009 |
| The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration JL Cummings, C Henchcliffe, S Schaier, T Simuni, A Waxman, P Kemp Brain 134 (11), 3146-3166, 2011 | 248 | 2011 |
| Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease V Ries, C Henchcliffe, T Kareva, M Rzhetskaya, R Bland, MJ During, ... Proceedings of the National Academy of Sciences 103 (49), 18757-18762, 2006 | 203 | 2006 |
| Metabolomic Profiling in LRRK2-Related Parkinson's Disease KK Johansen, L Wang, JO Aasly, LR White, WR Matson, C Henchcliffe, ... PLoS one 4 (10), e7551, 2009 | 170 | 2009 |
| Detection of retinal changes in Parkinson’s disease with spectral-domain optical coherence tomography GD Aaker, JS Myung, JR Ehrlich, M Mohammed, C Henchcliffe, S Kiss Clinical ophthalmology, 1427-1432, 2010 | 168 | 2010 |
| Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01 J Piao, S Zabierowski, BN Dubose, EJ Hill, M Navare, N Claros, S Rosen, ... Cell stem cell 28 (2), 217-229. e7, 2021 | 156 | 2021 |
| Data-driven subtyping of Parkinson’s disease using longitudinal clinical records: a cohort study X Zhang, J Chou, J Liang, C Xiao, Y Zhao, H Sarva, C Henchcliffe, ... Scientific reports 9 (1), 797, 2019 | 155 | 2019 |
| Sex and gender driven modifiers of Alzheimer’s: the role for estrogenic control across age, race, medical, and lifestyle risks A Rahman, H Jackson, H Hristov, RS Isaacson, N Saif, T Shetty, O Etingin, ... Frontiers in aging neuroscience 11, 461552, 2019 | 149 | 2019 |
| Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson’s disease (PD) O Westheimer, C McRae, C Henchcliffe, A Fesharaki, S Glazman, H Ene, ... Journal of Neural Transmission 122, 1263-1270, 2015 | 139 | 2015 |
| Cerebrospinal fluid, plasma, and saliva in the BioFIND study: relationships among biomarkers and Parkinson's disease features JG Goldman, H Andrews, A Amara, A Naito, RN Alcalay, LM Shaw, ... Movement Disorders 33 (2), 282-288, 2018 | 137 | 2018 |
| Genetic analysis of laminin A reveals diverse functions during morphogenesis in Drosophila C Henchcliffe, L García-Alonso, J Tang, CS Goodman Development 118 (2), 325-337, 1993 | 126 | 1993 |
| How are we doing with the treatment of essential tremor (ET)? Persistence of patients with ET on medication: data from 528 patients in three settings ED Louis, E Rios, C Henchcliffe European journal of neurology 17 (6), 882-884, 2010 | 119 | 2010 |
| Expression of c‐fos, c‐jun, and N‐terminal kinase (JNK) in a Development Model of Induced Apoptotic Death in Neurons of the Substantia Nigra T Oo, C Henchcliffe, D James, RE Burke Journal of neurochemistry 72 (2), 557-564, 1999 | 116 | 1999 |
| Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study C Huang, LD Ravdin, MJ Nirenberg, P Piboolnurak, L Severt, ... Dementia and Geriatric Cognitive Disorders 35 (3-4), 183-196, 2013 | 105 | 2013 |
| Elevated blood harmane (1-methyl-9H-pyrido [3, 4-b] indole) concentrations in essential tremor ED Louis, W Jiang, KM Pellegrino, E Rios, P Factor-Litvak, C Henchcliffe, ... Neurotoxicology 29 (2), 294-300, 2008 | 97 | 2008 |
| Effect of urate-elevating inosine on early Parkinson disease progression: the SURE-PD3 randomized clinical trial B Bluett, DM Togasaki, D Mihaila, M Evatt, M Rezak, S Jain, ... Jama 326 (10), 926-939, 2021 | 90 | 2021 |
